---
schema_version: "secwatch.filing_event.v1"
accession: "0001367644-25-000087"
form_type: "8-K"
ticker: "EBS"
cik: "0001367644"
company_name: "Emergent BioSolutions Inc."
filed_at: "2025-03-31T23:59:59+00:00"
generated_at: "2026-05-24T01:36:57.805806+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Emergent BioSolutions authorizes $50M share repurchase program through March 2026

## Summary
- Board authorized repurchase of up to $50 million of common stock on or before March 27, 2026.
- CEO Joe Papa cites confidence in strategy, future outlook and cash generation as rationale.
- Company had approximately 54.3 million shares outstanding as of December 31, 2024.
- Repurchases may be made on open market or in private transactions; timing subject to market conditions.

## SEC filing metadata
- accession: 0001367644-25-000087
- form_type: 8-K
- ticker: EBS
- cik: 0001367644
- company_name: Emergent BioSolutions Inc.
- filed_at: 2025-03-31T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367644/000136764425000087/0001367644-25-000087-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367644/000136764425000087/ebs-20250331.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001367644-25-000087
- JSON: https://secwatch.observer/filing/0001367644-25-000087.json
- Plain text: https://secwatch.observer/filing/0001367644-25-000087.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.